Pacira Pharmaceuticals, Inc.
News
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Globe Newswire TAMPA, Fla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...\n more…
Pacira BioSciences, Inc. (NASDAQ:PCRX) Not Doing Enough For Some Investors As Its Shares Slump 34%
Simply Wall St To the annoyance of some shareholders, Pacira BioSciences, Inc. ( NASDAQ:PCRX ) shares are down a considerable 34% in...\n more…
Pacira (PCRX) Down 27.9% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research A month has gone by since the last earnings report for Pacira (PCRX). Shares have lost about 27.9% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up...\n more…
Will Insiders Be Tempted To Buy More PCRX At The New 52-Week Low?
Market News Video In trading on Tuesday, shares of Pacira BioSciences Inc (PCRX) touched a new 52-week low of 11.16/share. That's a 27.07 share price drop, or -70.81% decline from the 52-week high of...\n more…
Where Pacira BioSciences Stands With Analysts
Benzinga In the latest quarter, 12 analysts provided ratings for Pacira BioSciences PCRX, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.\n more…
Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
Globe Newswire TAMPA, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...\n more…